FORT MYERS, Fla. (May 21, 2020) — On-site work has begun and is underway for construction of NeoGenomics’ new global headquarters, located just west of Interstate 75 and north of Alico Road along Three Oaks Parkway in Fort Myers. Seagate Development Group is the developer, construction manager and site contractor for the $60 million state-of-the-art facility. The project is scheduled to be completed by the third quarter of 2021.
On-site work began with the installation of silt fencing and clearing of the 14-acre site. In preparation to begin vertical construction, the site required importing an estimated 65,000 cubic yards of fill dirt to bring it to the proper elevation. Seagate Development was filling at a rate of 5,000 yards per day. Vertical construction is slated to begin this month.
NeoGenomics, Inc. is a leading provider of cancer-focused genetic testing services. The new 150,000-square- foot headquarters will be home to administration and an expanded laboratory. The cutting-edge facility will incorporate innovative technology to deliver comprehensive oncology testing for physicians and their patients.
Seagate Development Group, LLC new headquarters is located at 9921 Interstate Commerce Dr. in Fort Myers.
For additional information, contact (239) 738-7900. Visit SeagateDevelopmentGroup.com.
About Seagate Development Group
Seagate Development Group is a leading, full-service residential and commercial development and construction company specializing in new construction, custom renovations, interior design, and management and leasing services. The firm was formed by a group of real estate veterans who have created destination properties that have changed the landscape of our community. The company’s reputation continues to grow among architects, interior designers, real estate agents, engineers, tenants, homeowners and clients. The leadership team has the expertise and desire to deliver the highest quality product and a customer experience that exceeds expectations. For additional information about Seagate Development, visit www.SeagateDevelopmentGroup.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company’s Pharma Services Division serves pharmaceutical clients in clinical trials and drug development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and CAP accredited laboratories in Rolle, Switzerland, and Singapore.
NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia. For additional information about NeoGenomics, visit http://www.neogenomics.com/.